Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual melatonin for gastroesophageal reflux disease
IRCT20121021011192N12Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in gastroesophageal reflux disease (GERD), sponsored by Shahid Beheshti University of Medical Sciences. Started Nov 2021; status: completed.
02
Drugs
melatonin
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on IRCT20121021011192N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121021011192N12.